Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...
Smoothie King just launched its GLP-1 Support Menu with five specific smoothie blends to help support the journey of ...
Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...
With the rising popularity of telehealth providers offering GLP-1 medications ... or liquid drops, typically in a daily ...
Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.
One big idea has loomed over healthcare stocks over the past two years: Demand for the new GLP-1 weight loss medicines from ...
The researchers found a 25.6% drop in people undergoing bariatric ... the number of patients who took a glucagon-like peptide 1, or GLP-1 medication for weight loss, surged by more than 130% ...
Research led by a Northwestern Medicine team found that, despite higher upfront costs, bariatric surgeries offer two more quality years of life compared to GLP-1 therapies. The long-term cost ...
There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback